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Abstract
Background: Vaccine safety scares can undermine public confidence in vaccines and decrease immunisation rates.
Understanding and addressing parental concerns arising during such scares can assist in lessening their impact. In
Australia in April 2010 there was a temporary suspension of influenza vaccine for children under 5 years of age after
reports of an increase in the rate of adverse events following vaccination. This qualitative study aimed to explore
the impact of the vaccine suspension on parental knowledge, attitudes, trust, information needs, and intent related
to influenza vaccination and broader immunisation programs.
Methods: Semi-structured interviews were conducted with 25 parents of children attending childcare centres in
Sydney, Australia, between June 2010 and May 2011. Centres were selected to include parents from a range of
socioeconomic backgrounds. Interview transcripts were coded and analysed using an approach informed by
grounded theory.
Results: Findings indicated that, for those who recalled the vaccine suspension, there was a lasting sense of
uncertainty and confusion and a perceived lack of information. Parents had distinct information needs following
the vaccine suspension, especially in regards to vaccine safety, testing and recommendations. For many, influenza
vaccination intent was conditional on receipt of information from a trusted, authoritative source allaying safety
concerns. Importantly, the impact of the scare was contained to influenza vaccines only, and not other vaccine
programs.
Conclusions: Parental concerns and information gaps following a vaccine safety scare need to be actively
addressed. We provide policy and practice suggestions for proactively managing such incidents, particularly in
relation to communication of timely, targeted information to parents and immunisation providers.
Keywords: Australia, Influenza, Immunisation, Vaccine, Safety, Parents, Attitudes, Communication
Background
Vaccination safety scares have the potential to undermine
public confidence in vaccines and lower immunisation
rates, resulting in disease outbreaks and deaths. Scares
may remain unsupported or eventually be supported by
evidence. They may be amplified via mass media coverage
and can have sustained impacts [1–3]. The United
Kingdom’s (UK) measles-mumps-rubella vaccine (MMR)
scare began in 1998 with an assertion that the vaccine
could cause autism. This was refuted in further studies [4,
5], but still led to a reduction in MMR vaccine coverage in
England from 91.8% prior to the scare to a low of 79.9% in
2004 [6] and resultant disease outbreaks [7]. The UK
experienced a prior vaccine scare in the 1970s when the
diphtheria-tetanus-pertussis (DTP) vaccine was associated
with encephalopathy. Despite eventual evidence that this
possible association was extremely rare [8], public confi-
dence in the vaccine was eroded, including by negative
media reportage [9], and immunisation rates dropped
from 80 to 30% [10]. Subsequently, there was an outbreak
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of more than 300,000 pertussis cases, including 70
deaths [10]. In 1975 Japan suspended its whole-cell
DTP vaccination program following the deaths of two
children in December 1974 and January 1975 shortly
after they received the DTP vaccine [11]. The program
resumed in April 1975 [11] with a revised schedule
delaying the first dose until 2 years of age [12]. Pertussis
cases soared to over 13,000 in 1979, with 41 deaths [12]
compared to pre-scare levels of 393 cases and no deaths
in 1974 [11].
In April 2010 in Australia, an adverse event signal arose
following an increase in notifications of febrile reactions,
including convulsions, following influenza vaccination in
children [13]. Following epidemiological investigations,
there were 99 cases of febrile convulsions in children
under 5 years of age determined to have a causal rela-
tionship to administration of seasonal influenza vaccine
[14]. These convulsion cases occurred in states and terri-
tories across Australia, with the exception of the Northern
Territory. A higher proportion (58 cases) were reported in
Western Australia, where a state-based free influenza
vaccination program for children aged 6 months to 5 years
had commenced in 2008 [14].
Influenza vaccines have the potential to reduce
influenza-like illness morbidity in children [15], reduce
influenza virus transmission in the community [16] and
provide some herd immunity benefit [17]. In Australia,
influenza vaccination for young children above 6 months
of age is recommended but only funded by the Australian
National Immunisation Program (NIP), for those deemed
susceptible to severe influenza disease or resultant compli-
cations [18, 19]. During the 2009 H1N1 influenza pan-
demic, a monovalent H1N1 vaccine was registered in
Australia from December 2009 for children aged 6 months
to 9 years and provided free of charge by the Australian
Government [20]. The subsequent 2010 trivalent seasonal
influenza vaccine included the H1N1 strain in combin-
ation with an A/H3N2 and a B strain but was only funded
for those with identified risk factors [20].
Following detection of the adverse events signal re-
lated to influenza vaccine in children, the Chief Medical
Officer of Australia suspended the use of all inactivated
trivalent influenza vaccines for children under 5 years
of age on 23 April 2010 [13]. An investigation was con-
ducted into the possible cause (s) of the adverse events
signal, and found that it was related to only one brand
of influenza vaccine [21]. On 30 July 2010, use of other
brands of influenza vaccines for children was resumed
[22], while the suspension of the affected vaccine
remained in force. An investigation into the affected
vaccine, manufactured by bioCSL, continued and an offi-
cial report was publicly released on 25 May 2011 [23, 24].
The eventual cause was theorised to be an interaction
between viral components in the vaccine that resulted in
an overly robust immune response and/or possible manu-
facturing process issues [25–27].
Parental confidence in vaccine programs can be a key
factor influencing vaccine uptake [28]. Although vaccine
safety scares and their impacts are well known and can
include prolonged drops in vaccination rates, often years
after the safety issue has been resolved [29], little re-
search has investigated how parents themselves respond
to these scares in their own words. Few if any have done
so in real time during the evolution of the scare.
This study aimed to elicit an understanding of parental
knowledge, attitudes and beliefs about the vaccine sus-
pension. In particular, it aimed to explore the impact of
the suspension on parental trust in influenza vaccine (in-
cluding future influenza vaccination intent), emerging
information needs and other immunisation programs.
Methods
The study was conducted alongside a wider study examin-
ing the social, economic and health benefits of influenza
prevention in children attending day care centres. This
study was funded by an Australian Research Council
grant. Ethics approval for the study was obtained from the
Human Research Ethics Committee of The Children’s
Hospital at Westmead.
One of the key research partners was a provider of
early childhood education and long day care services in
72 centres across the Sydney metropolitan area. [30] The
Australian Bureau of Statistics Socio-Economic Indexes
for Areas (SEIFA) postcode data [31] was used in the se-
lection of three centres for the study, to ensure inclusion
of centres from different geographic and socioeconomic
areas. The centres selected had SEIFA scores of 938.88,
1092.96, and 1122.7 respectively; a higher score is linked
to a higher socioeconomic rating for that postcode area.
Parents with at least one child (aged 0–6 years) en-
rolled were recruited from the three selected childcare
centres. Prior to recruitment, one researcher (CK) met
with each childcare centre director to explain the study
in detail. Information sheets about the project were pro-
vided to each centre director, who arranged for them to
be displayed in the centre and emailed to all parents of
children enrolled in the centre.
During recruitment, parents were generally approached
as they were leaving the Centre after dropping off their
child(ren); some parents directly approached the recruiter
to ask about the study upon arrival at the Centre. Parent
contact details were recorded and then parents were con-
tacted by telephone or email (depending on parental pref-
erence) to organise an interview time. Care was taken not
to oversample from any particular centre.
Semi-structured qualitative interviews (n = 25) were
conducted by one researcher (CK). The interviews oc-
curred over three key time-points during June/July 2010,
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October/November 2010 and May 2011, with different
parents interviewed using the same interview schedule
at each time-point. This allowed for the collection of
data in the immediate aftermath of the vaccine suspen-
sion, after the resumption of the non-affected influenza
vaccines for children, and prior to the beginning of the
southern hemisphere 2011 influenza season, respectively.
These time-points and major key events are noted in
Table 1.
Participants were given the option of face-to-face or
telephone interviews at a time and location convenient
to them. All participants elected to participate in tele-
phone interviews. Consent for study participation and
recording of the interviews was obtained from each
participant.
Topic domains covered in the interview included par-
ental knowledge and thoughts about influenza disease
(both seasonal and pandemic H1N1), influenza vaccines
for children and the vaccine suspension, including its
impact on trust and intent for both influenza vaccination
and other vaccination programs. Parental information
needs, including preferred information formats and de-
livery mechanisms, were also explored in relation to the
vaccine suspension.
Throughout the interviews, the interviewer (CK) used
intra-interview checking techniques to ensure that the
participant responses had been correctly understood.
Notes were taken during the interviews concurrent with
audio recording. Participants were encouraged to consult
a medical practitioner for answers to any specific clinical
questions about their child(ren) arising during interviews.
Interview recordings were transcribed word-for-word
by a professional transcription service shortly after a
batch of two to three interviews was conducted. This
timely transcription allowed for ongoing analysis by the
researchers to guide the subsequent interviews. Inter-
views were conducted until theoretical saturation of
concepts was reached with no additional divergent
cases identified.
Transcripts were imported into qualitative research
software NVIVO 10 (QSR International, 2012). Line-by-
line coding was undertaken and coding was initially
linked to major question areas. The authors met to dis-
cuss and refine emerging higher order themes. Analysis
was informed by grounded theory methodology, which
emphasises the derivation of theory from the data [32].
Particular attention was paid in the analysis to seeking
out exceptions diverging from the predominant findings.
Information on the key time-points of major events
associated with the vaccine suspension was collected
(see Table 1). This, together with situational analysis
which stems from grounded theory and maps key influ-
ences existing throughout the research period [33], was
used to explicitly consider the complex context that
existed at the time of the study to aid understanding of
the participants’ responses. This included the recent
2009 influenza pandemic (which although milder than
early predictions still caused an estimated 123,000–
203,000 deaths worldwide in 2009) [34], development
and use of a monovalent pandemic vaccine and subse-
quent use of a trivalent vaccine including the pandemic
strain, and finally the suspension of the vaccine. Broader
societal factors and potential influences on parents and
the linkages between these were also mapped to inform
the analysis.
Results
Twenty-five semi-structured interviews were conducted.
Of these, 9 interviews were conducted in June/July 2010, 8
in October/November 2010 and 8 in May 2011. A sum-
mary of participant demographic information is contained
in Table 2.
Situational analysis of the context for the interviews
identified the following key constructs with the potential
to intersect with the emerging themes from the inter-
views: societal concepts of disease; disease experiences –
both personal and of contacts; proximity to perceived risk;
parental time constraints; influencers – family, friends and
Table 1 Timeline of key events in relation to interview schedule
Date Context Interview timing
Mar 2010 Initial reports of febrile
convulsions following receipt of seasonal influenza vaccine
23 Apr 2010 Influenza vaccine suspended for children under 5 years of age
June 2010
2 July 2010 Therapeutic Goods Administration (regulator) initial report released July 2010
30 July 2010 Use of non-bioCSL vaccines resumed
24 Sept 2010 Therapeutic Goods Administration (regulator) updated report released
8 Oct 2010 Therapeutic Goods Administration (regulator) overview report released October 2010
November 2010
25 May 2011 Final investigation findings released (day after last interview concluded) May 2011
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health professionals; and broader societal parenting
expectations.
Pseudonyms are used in the reporting of the findings to
preserve the confidentiality of interview subjects, with
direct quotes also listing the month and year obtained to
enable transparency as to the contextual background. The
following themes emerged from the analysis and were
evident and consistent across the three interview time-
points in the study: ‘Uncertainty and unease’, ‘Interaction
with existing perspectives’, ‘Tried and true – the ‘normal’-
vaccines’, ‘Mind the gap’ - the information void’ and
‘Bridging the gap – parental information preferences’.
Uncertainty and unease
The majority of interviewees had some knowledge that a
vaccine suspension had occurred. However, this know-
ledge was largely incomplete and characterised by confu-
sion as to what had happened, where it had occurred
and what vaccines were involved. Some participants
recognised that influenza vaccine was involved, but were
unsure whether it was the H1N1 ‘swine flu’ vaccine or
the seasonal influenza vaccine.
The overall recollection of parents was a negative one
created by the overriding perception that something ‘bad’
had happened with children perhaps killed or severely ad-
versely affected. As outlined by Renuka in July 2010, three
months after the vaccine suspension occurred,
I have information stored in my brain that it’s gone
wrong and after that there was no news at all.
This negative impression persisted even in the inter-
views completed after the non-bioCSL vaccines were
available again. As Marina interviewed in May 2011,
thirteen months after the suspension relayed,
I don’t know if kids died, or something was wrong
with the vaccine, and they just stopped giving or
something like that.
Most of the parents interviewed had heard directly
about the vaccine suspension from the media including
via television reports, radio, online sources and newspa-
pers. No parents mentioned knowing that other influ-
enza vaccines for children were available for use, despite
16 of the 25 interviews being conducted after use of the
non-affected vaccines had resumed.
A sense of unease about the influenza vaccine for
children was evident from parental responses. Those
who had previously contemplated vaccinating their
child(ren) against influenza were now hesitant to do so.
For example, as explained by Penny in July 2010,
I was debating on whether to do it and then there
were those cases on TV where the people had kids
who’d got sick …so I left it.
This unease was related in part for some parents to
the reponsibilty they felt as parents making health
decisions for their child(ren). As articulated by Tara in
June 2010,
it is a bit alarming you know thinking that you know
moving forward if you were to get the injection you
know, would some of this happen? The kids are
obviously so precious as you know, and you would
be to blame, like me as the parent. I mean yes, there
would obviously be someone else to blame, but you
would feel '…you knew about this, you had it done
and then you know something's happened'.
Interestingly, some parents indicated that they would
proceed with their own influenza vaccinations, despite a
reluctance to immunise their child(ren) against influenza.
As outlined by Rachel in October 2010,
I have no intention of taking them [the children] in to
get the flu shots next year, unless something triggers
me to do it, whereas just for me, yes I will go and get
my flu shot.
Interaction with existing perspectives
Parents’ pre-existing beliefs about influenza disease and
the influenza vaccine were an important context in which
they interpreted the vaccine suspension. Many parents
believed influenza to be a very mild illness, which in part
appeared attributable to a general confusion about what
constituted influenza disease compared to the common
cold. In describing both her own confusion and that of
others Yasmin stated in October 2010,
I get very confused about colds and flus and things
like that, and I suppose a general cold isn’t that
serious, but a flu can sometimes be a little bit more
Table 2 Demographic information – interview participants
Parents 24 mothers, 1 father
Age under 21 years (n = 1)
21–30 years (n = 2)
31–40 years (n = 19)
41–50 years (n = 3)
Country of birth Australia (n = 17)
Overseas (n = 8)
Education University degree (n = 16)
TAFE (vocational training college) (n = 2)
Completed 6 years secondary school (n = 5)
Completed 4 years secondary school (n = 2)
Employment Outside the home (n = 18)
Home duties (n = 7)
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debilitating …I think most people refer to whatever
they’ve got, whether it be a cold or anything else, it’s
always referred to generally as a flu.
Actual experience of influenza illness lent clarity to
the distinction between colds and influenza, with influ-
enza then being perceived as very serious. For some par-
ents, the H1N1 influenza pandemic had heightened
awareness and concerns about influenza.
For others the pandemic and its attendant media atten-
tion had functioned to de-escalate concerns about influ-
enza, in particular when initial predictions about pandemic
severity were not borne out in people’s experience.
The high level of dread associated with other illnesses
was not apparent for many parents, allowing them to
rationalise concerns and establish a view of influenza
vaccine as unnecessary. As mentioned by Jessica in
October 2010,
If a child gets polio or rubella, I think the consequences
can be life threatening…but my understanding is
generally if you treat flu well, and your children don’t
have any underlying health problems, it’s not usually a
fatal illness … in my mind the other illnesses are much
more serious.
Many parents felt their child(ren) were healthy enough
to resist influenza infection and/or complications and that
it could be prevented by handwashing and a healthy diet.
Some parents were confused by the need for annual
vaccination, with variable awareness of the need to match
the vaccine to currently circulating influenza strains.
Others thought it may be beneficial to allow their child to
contract influenza to build immunity from the wild
disease, rather than by vaccination.
Parents who had existing concerns about influenza
vaccination for their child(ren) solidified their opposition
to it following the vaccine suspension. Several parents
stopped or delayed plans to have their child(ren) vacci-
nated against influenza. For some the decision was also
related to practical barriers such as lack of time.
For one respondent the vaccine suspension provided
reassurance that Australia has a robust vaccine safety
system. For this parent, the fact that a problem vaccine
was identified, removed and investigated by relevant
authorities was evidence that the system was working
effectively.
Tried and true – the ‘normal’ vaccines
The impact of the suspension on parental trust appeared
to be limited to the influenza vaccine alone. For most
participants, the suspension had no impact on their con-
fidence in other vaccines or established vaccination pro-
grams. Parents expressed familiarity with vaccinations
they had received as a child, with the success and lon-
gevity of these programs contributing to a sense that
these vaccines were well known, understood and ad-
equately tested.
The perceived stability of the formulation of existing
vaccines was contrasted with the ever-changing nature
of influenza vaccines. Parents were concerned that the
annual need to change formulations may leave inad-
equate time for proper testing. As discussed by Rachel
in October 2010,
Other vaccinations yes, they’re proved and tested
vaccines, whereas …the flu ones, because they keep
changing yes I think they’re the riskier ones.
The established funded NIP was seen as an essential
and routine part of childhood by virtually all the parents
interviewed. In contrast, the exclusion of influenza vac-
cine from the funded program suggested to some par-
ents that it was at best optional, and at worst potentially
unsafe. As articulated by Ingrid in July 2010,
I don't have a problem getting them immunised
from anything else – probably because it's been
a government issued, um, almost stipulation now
and it's paid for by the government, so I suppose
I maybe naively think that they must be completely
safe …. whereas the flu one is still voluntary, and
I think well if it's voluntary maybe it's not safe
enough.
A divergent view was expressed by one parent, Mandy,
interviewed in November 2010, who felt that the vaccine
suspension had impacted negatively upon her view of all
vaccines, making it difficult for her to allow her child to
have any vaccines. This hesitancy was linked to other
vaccine scares (MMR) with her stating “the whole aut-
ism thing rings in my ears”.
‘Mind the gap’ - the information void
In contrast to long-established vaccine programs, many
parents described a lack of information about the influ-
enza vaccine suspension. Initial reporting about the sus-
pension but then no further updates left parents unsure
what to do, and allowed for the persistence of a negative
impression about influenza vaccination of children. As
expressed by Alexandra in May 2011,
I don’t have any up-to-date information, so I don’t
know what's happened since then, what they found. I
remember that there was some controversy and they
suspended it, but …especially now it’s coming up to
winter, I don’t know what the updated situation is on
that, or whether it’s okay to do the vaccine or not.
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Conflicting advice from their General Practitioner
(GP) added to confusion for some parents with some
GPs still advising that no influenza vaccines were recom-
mended for children under 5 years of age as late as May
2011, despite non-affected vaccines being officially re-
sumed for children less than 5 years of age from 30 July
2010.
Clear information gaps emerged throughout the inter-
views. Some parents expressed a desire to know more
about the severity of influenza disease, the need for, and
composition of, influenza vaccine for children and how
seasonal strain change affects vaccine testing. Many par-
ents advanced specific and detailed information needs
about the suspension, particularly concerning safety,
testing and investigative outcomes. For example, as
Anna queried in May 2011,
what the likelihood of side-effects are and who it’s
been recommended by and what kind of cover it
provides?
Despite the regulatory authority, the Therapeutic Goods
Administration conducting investigations and writing
reports throughout the period of the interviews (see
Table 1), no parent reported hearing about the existence
or outcomes of these. Question areas about the suspen-
sion articulated by parents included:
 What exactly occurred?
 Who was affected?
 Why were they affected?
 What side effects were there?
 What is in the vaccine?
 What were the existing recommendations?
 What are the recommendations post-suspension?
 Is it safe now?
 What testing has been done?
 What was the outcome of an investigation?
 Who has recommended the use of this vaccine?
The provision of information from a reliable source to
meet these information needs was a pre-condition for
most parents to contemplate influenza vaccination of their
child(ren). As stated by Ingrid in July 2010,
So until a report comes out, either on the TV or
the newspaper, that tells us that there've been some
successful studies now and it's all okay, uh, until
then, I wouldn't consider it.
A small number of parents would still consider vaccin-
ating their child(ren) against influenza. Reasons advanced
for this included the future commencement of school by
their child(ren), living with family members vulnerable to
severe influenza infection, the impending birth of a baby,
and potential financial difficulties if the primary income
earner contracted influenza.
Bridging the gap – parental information preferences
Parents mentioned a range of information sources, for-
mats and delivery mechanisms that would be useful for
meeting their expressed information needs. Great import-
ance was placed on information being from a trustworthy
and reputable source.
GPs were acknowledged as a trusted source of infor-
mation for many. However, obtaining information from
GPs was not always seen as a practical solution as GPs
were not immediately accessible and only consulted if a
family member was unwell.
Instead, freely accessible, authoritative sources of in-
formation were preferred.
As Elena stated in June 2010,
I wouldn't go out of my way to go visit a GP just to
ask these questions – but by all means if it was online
on some sort of you know, secure government
website, then yes, absolutely.
Parents mentioned a range of formats and distribution
mechanisms useful for suspension-related information.
This included broadcasts via traditional media sources
such as radio and television, as well as hard copies of
information in brochure or poster form at locations in-
cluding childcare centres, healthcare centres and libraries.
There was recurrent mention of lack of time availability
impact on when and how information could be accessed.
For many parents this led to a strong preference for
internet-based information, which could be accessed after
hours.
Unfortunately, for some parents there was now a gap in
trust levels that would be hard to overcome with informa-
tion provision alone. As stated by Paula in May 2011,
I mean it probably wouldn’t matter what was said
now, I would feel that there was also a chance that
something could go wrong.
Discussion
This study provides detailed, contextualised informa-
tion about how parents of young children responded to
a vaccine safety scare. To our knowledge this is the only
qualitative study examining parents’ responses to the
Australian 2010 influenza vaccine scare at key time
points as it evolved. The scare did not arrive in a vac-
uum of perceptions and beliefs about the influenza vac-
cine. Rather, it interacted with existing views whereby
parents used the narrative in diverse ways to make
meaning about child health, risk, influenza and its
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vaccine. The study also found that parents experienced
considerable uncertainty about the vaccine that
stemmed from a gap in information provision in the
post-suspension period and that this uncertainty was
evident at each interview timepoint. Their knowledge
of the vaccine suspension was minimal, with many hav-
ing a negative recollection of events with very little pre-
cision in their knowledge of the suspension and
resumption of non-affected vaccines. Having identified
this gap, many openly expressed a desire to know more,
including via the mass media and other passive sources,
although only a few expressed an intention to actively
seek out information.
The vaccine suspension, affecting as it did young chil-
dren, could be considered an event of high ‘dread’ [35]
in which there is the potential for a high level of what
Sandman terms ‘outrage’ [36]. The negative gist parents
associated with the influenza vaccine can be explained
by fuzzy trace theory. This asserts that the gist response
to an event can often be more strongly recalled than the
detail of the event itself and risk information processed
according to the essence of the recollection [37, 38]. In-
dividual meanings, pre-existing knowledge and feelings
interact to try to achieve sense-making about an issue
[39]. In this study, initial hesitancy about influenza vac-
cine being viewed as optional, less necessary and con-
stantly changing was amplified by the suspension and
functioned to validate parental concerns.
Parental decision making about vaccination risk, is
complex and individualized [40, 41]. The situational
analysis conducted as part of this study illuminated the
many complex structural and social systems parents
interact with and that form a backdrop to risk process-
ing. Parents, especially mothers, are subject to in-
creased scrutiny about health decision making for their
child(ren) from both peers and wider society [42]. In
parallel to this, increasingly sophisticated technologies
and bodies of knowledge make it impossible for indi-
viduals to completely understand all aspects of every
topic, forcing some reliance on experts to translate
these to a lay audience [43, 44].
In this study, advice from ‘experts’, in this instance GPs,
about the safety of the vaccine sometimes conflicted with
regulatory advice. Another Australian study noted that
practitioner confusion existed around the post-suspension
recommendations, with 13% of GPs advising against re-
ceipt of the childhood influenza vaccine during the period
2010–2012 [45].
Negative media reporting can lessen uptake of vac-
cination during and/or following vaccine safety scares
[46, 47]. Mass media reportage of issues is driven by what
is considered currently newsworthy [35, 48]. During the
vaccine suspension, government agencies reacted to deter-
mine the cause of the higher rate of adverse events, a
process that necessarily took considerable time. Media at-
tention moved on from the suspension story. The absence
of clear messages from trusted heath authorities via the
media at this time created an information void for parents,
inadvertently allowing the perpetuation and persistence of
a negative association. Parents did not understand the
nuance around one vaccine remaining suspended while
the other vaccines were deemed safe, and vaccination
intent was affected.
A qualitative study conducted in the UK to examine
parents’ views of the MMR vaccine controversy deter-
mined that health scares increase parental information
needs, particularly in relation to future vaccination
intent [49]. Recent evidence suggests that vaccine
hesitant parents may not necessarily be persuaded by
information provision and well-reasoned argument
[50]. However, it appears that for many study parents,
in the circumstance of the suspension, vaccination was
conditional on the provision of a clear safety message
via authoritative sources. A government report [24]
was finalised but not publicly released before the com-
pletion of this study, so it is not known what impact, if
any, this would have had on parents’ views.
The qualitative findings in this study, that confidence
in the NIP vaccines largely remained while confidence
in influenza vaccines was eroded, are supported by
quantitative Australian studies, including a survey con-
ducted in 2010 among parents whose child had experi-
enced an adverse event from a vaccine (including both
influenza and NIP vaccines) [51]. Another survey, con-
ducted in Western Australia where a funded program
existed, examined the impact of the paediatric influenza
vaccine suspension on vaccination coverage rates. It
found that childhood influenza vaccination rates de-
creased from 45.5% in 2009 to 7.9% in 2010 and 17.3%
in 2011, but there was no decrease in coverage rates for
the NIP-funded vaccines [52]. A further study tracking
vaccine uptake and parental attitudes towards the influ-
enza vaccine for young children from 2010–2014, con-
cluded that vaccine uptake remains low following the
2010 adverse events, with 41.7% of children fully vacci-
nated in 2008–2009 compared to 7.1% in 2010–2014.
This decrease was noted both in healthy children and
in those with comorbidities placing them at a higher
risk of influenza disease. There was a slight rise in in-
fluenza vaccine uptake in children with comorbidities
in 2014, however, the results were not statistically sig-
nificant [53].
Limitations
This study contained a majority of highly educated par-
ents, thus may have under-represented the views of less
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educated parents, despite sampling from childcare centres
across a diverse range of socioeconomic areas.
Implications for public health
There is a need for public health authorities to be pro-
active during an adverse events incident and engage
with both parents and providers. We have shown that
agencies cannot rely on the message getting through via
other sources or parents actively seeking out informa-
tion. Well-established crisis communication principles
should be utilised. These include keeping the many
publics (and professionals) informed, acknowledging
uncertainty and showing respect for concerns expressed
[35, 36, 54, 55]. Thus, even in the absence of clear find-
ings from an investigation, some attempts to keep the
public informed should be undertaken, including com-
munication of what is known and not yet known and
what is being done to address the gaps.
Information should be tailored to different audiences
to meet them at their point of need, with a balance of
straightforward messages backed by further details for
those who require this [35]. In the instance of the sus-
pension, parents requested clear, consistent follow-up
advice and recommendations for action particularly
when approaching key decision points such as the be-
ginning of the new influenza season. Trust needs to be
rebuilt in regards to the safety of the influenza vaccine
and specific information gaps met, including via two-
way dialogue [35] with parents.
Given the fragmented sources accessed by parents,
information should be disseminated via multiple means.
Traditional media sources should be used, but given the
likelihood that media interest may quickly wane, other
trusted sources should also be utilised, such as distribut-
ing information resources via childcare centres and pro-
viding authoritative information on government health
websites. Although not mentioned in this study, the pro-
liferation and increase in use of social media sites since
the study make it likely that dissemination using this
means may also be beneficial.
Immunisation providers, such as GPs and nurses,
should be specifically targeted with up-to-date informa-
tion, including ready-made resources to discuss with or
give to parents. Finally, capacity in health systems should
be built to ensure the ability to cope with increased in-
formation needs during and after health scares, includ-
ing detailed planning for who will communicate during
a vaccine safety scare and how.
Conclusion
This qualitative study found that the suspension of the
influenza vaccine for children under 5 years of age had a
negative impact on parental views about that vaccine
during June 2010-May 2011. Parents in this study
displayed hesitancy about their children being vaccinated
against influenza. For most parents, their concern was
linked to perceived inadequate information provision.
The negative impact of future vaccine scares could po-
tentially be mitigated by the provision of clear, concise
information about the progress of investigations, the re-
search and testing undertaken, and by giving clear direc-
tion about when vaccination can be resumed.
Reassuringly, even though this event generated un-
certainty around the influenza vaccine, with the excep-
tion of one divergent case it did not affect trust for
long-established vaccination programs. However, as
demonstrated by the impact on immunisation rates
from other vaccine scares, public health officials need
to be proactive in dealing with future vaccine scares
and ready to disseminate clear, targeted information to
both parents and immunisation providers.
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